AIDS DRUG ASSISTANCE PROTOCOL
FUND
  ADAP Main Page

New and Noteworthy
 Prioritization Guidelines
 Ethical Challenges   
Position Papers 
General ReportsState Challenges
NASTAD Reports
 Case Management

 

 Program Analyses 
Medicare and ADAP
Journal of Timely and Appropriate Care



 








 
 
US AIDS Drug Access Main Page    
LAST UPDATE  December 08, 2014
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     

February 2014
 
General Reports
       

    Journal Papers, Abstracts, and Commentaries
 
 
Integrating Substance Abuse Treatment into HIV Care: Missed Opportunities in the AIDS Drug Assistance Program.
Martin EG, Wang KH.
J Acquir Immune Defic Syndr. 2012 Nov 29
 Abstract

The Impact of the AIDS Drug Assistance Program (ADAP) on Use of Highly Active Antiretroviral and
Antihypertensive Therapy among HIV-Infected Women.
Yi T, Cocohoba J, Cohen M, et alJ
Acquir Immune Defic Syndr. 2010 Dec 25
 Abstract

Improving Outcomes in State AIDS Drug Assistance Programs.
Linas BP, Losina E, Rockwell A, et al 
J Acquir Immune Defic Syndr. 2009 Jun 25
 Abstract

AIDS Drug Assistance Programs in the Era of Routine HIV Testing.
Bassett IV, Farel C, Szmuilowicz ED, Walensky RP.
Clin Infect Dis. 2008 Jul 21.
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
Market power and state costs of HIV/AIDS drugs.
Leibowitz AA, Sood N.
Int J Health Care Finance Econ. 2007 May 5;
 Abstract
 
Optimizing resource allocation in United States AIDS drug assistance programs.
Linas BP, Zheng H, Losina E. et al
Clin Infect Dis. 2006 Nov 15;43(10):1357-64
 Abstract
 
The relationship between HAART use and employment for HIV-positive individuals:
an empirical analysis and policy outlook.
Bernell SL, Shinogle JA.  
Health Policy. 2005 Feb;71(2):255-64.
 Abstract
 
FULL-TEXT ARTICLE
 Advocate Profiles: William E. Arnold
Hinchey M  Darwell  W
JTAC January 2004
Paper

AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency
virus-infection health care in the United States.
Walensky RP, Paltiel AD, Freedberg KA.
Clin Infect Dis. 2002 Sep 1;35(5):606-10.
 Abstract
 
State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly
changing treatment standards.
Johri M, David Paltiel A, et al
Med Care. 2002 May;40(5):429-4
Abstract

'The AIDS drug assistance programs and coverage of HIV-related medications.
Smith SR, Buchanan RJ.
Ann Pharmacother 2001 Feb;35(2):155-66
Abstract
 

  
      Conference Reports, Abstracts, and Commentaries
 
  Access to HIV treatment, care and prevention from persons living with HIV/AIDS:
results of a comprehensive survey of ADAP recipients
 L.R. Frank, J. Folby, J. Pease
 (XVII International AIDS Conference)
 Abstract

     Internet Documents

 
FULL TEXT ARTICLE
 John Hawes Interviews Kit N Simpson, DrPH on her New Cost-of Care Model for HIV Care
 Simpson, KN, Hawes J
Thoughtleaders January 2008  Volume 3   Number 1 
 Interview

 
Ethical Challenges
       
     Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT PDF ARTICLE
Legislative Ethics in the HIV/AIDS Pandemic
Gostin LO
JTAC January  2004
 PDF Paper
 
FULL-TEXT COMMENTARY
 Yin, Yang, and Tuskegee-Lite: Ethical Concerns Over HIV Testing in ADAP-
 Challenged States
 Nary G
June 24, 2003
 Commentary
Medicare and ADAP
       
     Journal Papers, Abstracts, and Commentaries
 
  Medicare Part D drug benefit and HIV/AIDS: questions and answers.
Valenti WM.
 AIDS Read. 2006 Feb;16(2):66
 Abstract

US AIDS Drug Access Main Page    

AIDS Drug Assistance Program Main Page